207 related articles for article (PubMed ID: 10511836)
1. Lifetime health and economic benefits of weight loss among obese persons.
Oster G; Thompson D; Edelsberg J; Bird AP; Colditz GA
Am J Public Health; 1999 Oct; 89(10):1536-42. PubMed ID: 10511836
[TBL] [Abstract][Full Text] [Related]
2. Lifetime health and economic consequences of obesity.
Thompson D; Edelsberg J; Colditz GA; Bird AP; Oster G
Arch Intern Med; 1999 Oct; 159(18):2177-83. PubMed ID: 10527295
[TBL] [Abstract][Full Text] [Related]
3. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
[TBL] [Abstract][Full Text] [Related]
4. A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.
Lamotte M; Annemans L; Lefever A; Nechelput M; Masure J
Diabetes Care; 2002 Feb; 25(2):303-8. PubMed ID: 11815500
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.
Hamilton VH; Racicot FE; Zowall H; Coupal L; Grover SA
JAMA; 1995 Apr; 273(13):1032-8. PubMed ID: 7897787
[TBL] [Abstract][Full Text] [Related]
6. The economic cost of obesity: the French situation.
Lévy E; Lévy P; Le Pen C; Basdevant A
Int J Obes Relat Metab Disord; 1995 Nov; 19(11):788-92. PubMed ID: 8589779
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
[TBL] [Abstract][Full Text] [Related]
8. Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
Cawley J; Meyerhoefer C; Biener A; Hammer M; Wintfeld N
Pharmacoeconomics; 2015 Jul; 33(7):707-22. PubMed ID: 25381647
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of obesity-related chronic diseases in Mainland China.
Zhao W; Zhai Y; Hu J; Wang J; Yang Z; Kong L; Chen C
Obes Rev; 2008 Mar; 9 Suppl 1():62-7. PubMed ID: 18307701
[TBL] [Abstract][Full Text] [Related]
10. The economic impact of obesity. Building bridges with managed care.
Wolf AM
Postgrad Med; 2001 Jun; 109(6 Suppl):34-9. PubMed ID: 19667566
[TBL] [Abstract][Full Text] [Related]
11. The 25-year health care costs of women who remain overweight after 40 years of age.
Gorsky RD; Pamuk E; Williamson DF; Shaffer PA; Koplan JP
Am J Prev Med; 1996; 12(5):388-94. PubMed ID: 8909650
[TBL] [Abstract][Full Text] [Related]
12. Optimal waist circumference cut-off values for predicting cardiovascular risk factors in a multi-ethnic Malaysian population.
Cheong KC; Ghazali SM; Hock LK; Yusoff AF; Selvarajah S; Haniff J; Zainuddin AA; Ying CY; Lin KG; Rahman JA; Shahar S; Mustafa AN
Obes Res Clin Pract; 2014; 8(2):e154-62. PubMed ID: 24743011
[TBL] [Abstract][Full Text] [Related]
13. Economic and humanistic outcomes associated with comorbid type-2 diabetes, high cholesterol, and hypertension among individuals who are overweight or obese.
Kannan H; Thompson S; Bolge SC
J Occup Environ Med; 2008 May; 50(5):542-9. PubMed ID: 18469623
[TBL] [Abstract][Full Text] [Related]
14. What are the benefits of moderate weight loss?
de Leiva A
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():10-3. PubMed ID: 9792475
[TBL] [Abstract][Full Text] [Related]
15. The medical cost of cardiometabolic risk factor clusters in the United States.
Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of diet and exercise interventions to reduce overweight and obesity.
Forster M; Veerman JL; Barendregt JJ; Vos T
Int J Obes (Lond); 2011 Aug; 35(8):1071-8. PubMed ID: 21224825
[TBL] [Abstract][Full Text] [Related]
17. The future burden of obesity-related diseases in the 53 WHO European-Region countries and the impact of effective interventions: a modelling study.
Webber L; Divajeva D; Marsh T; McPherson K; Brown M; Galea G; Breda J
BMJ Open; 2014 Jul; 4(7):e004787. PubMed ID: 25063459
[TBL] [Abstract][Full Text] [Related]
18. Modeling Obesity in Norway (The MOON Study): A Decision-Analytic Approach-Prevalence, Costs, and Years of Life Lost.
Bjørnelv GMW; Halsteinli V; Kulseng BE; Sonntag D; Ødegaard RA
Med Decis Making; 2021 Jan; 41(1):21-36. PubMed ID: 33256539
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease.
Chen F; Su W; Becker SH; Payne M; Castro Sweet CM; Peters AL; Dall TM
PLoS One; 2016; 11(10):e0163627. PubMed ID: 27706216
[TBL] [Abstract][Full Text] [Related]
20. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery.
Vogel JA; Franklin BA; Zalesin KC; Trivax JE; Krause KR; Chengelis DL; McCullough PA
Am J Cardiol; 2007 Jan; 99(2):222-6. PubMed ID: 17223422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
